Cantor Fitzgerald analyst Pablo Zuanic rates Verano at overweight, while Planet 13 and Ascend Wellness receive neutral ratings
More Stories
Cerebras IPO filing points to a recurring concern in AI: customer concentration
The much-anticipated IPO by Cerebras Systems — the first chip maker of the AI era to go public — also...
CVS is reportedly reviewing its options — including a possible breakup
Drugstore chain CVS Health Corp. in recent weeks has been reviewing its options as a company — among them a...
Hasbro and Mattel have most toy shipments locked in as port strike looms, analysts say
A strike along dozens of East Coast ports could cost the economy hundreds of millions of dollars a day, leaving...
Here’s what’s worth streaming in October 2024: ‘Heartstopper,’ ‘The Diplomat,’ ‘Shrinking’ and more
Hulu’s ‘What We Do in the Shadows’ and Max’s ‘Somebody Somewhere’ return for their final seasons
Stocks, bonds up in third quarter amid ‘soft landing’ hopes — but gold beat both
Markets wrapped up a strong third quarter for stocks and bonds, as investors appeared more convinced that the Federal Reserve...
AI chip startup Cerebras files for IPO, in market dominated by Nvidia
Cerebras Systems Inc., a maker of chips and other tech infrastructure for artificial intelligence, filed for an initial public offering...